drugset / Trial / NCT07085975

The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges

NCT07085975

Phase 1 Recruiting 33 enrolled McMaster University
NaSingle-groupOpen-labelDiagnostic

Summary

The inhalation of adenosine 5'-triphosphate (ATP) to evoke cough (ATP cough challenge) is becoming increasingly used as a tool to measure cough hypersensitivity in patients with chronic cough. However, the safety, feasibility, and repeatability of this procedure is not widely known. In this study, we will perform ATP cough challenges in healthy individuals and in patients with mild asthma and chronic cough to better understand the safety, feasibility, and repeatability of these challenges. Such information will guide the future conduct of ATP cough challenges to measure cough hypersensitivity and identify patients who may better respond to ATP-blocking therapies.

Timeline

Start
2025-08-05
Primary completion
2026-08-01
Completion
2026-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject adenosine triphosphate Small molecule Inhaled

Indications